Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment
about
Revisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behaviorPharmacotherapy for stimulant-related disordersRecent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug developmentCommon and distinct neural targets of treatment: changing brain function in substance addictionPsychostimulant treatment of cocaine dependenceA debate on working memory and cognitive control: can we learn about the treatment of substance use disorders from the neural correlates of anorexia nervosa?Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys.PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivityEnhanced midbrain response at 6-month follow-up in cocaine addiction, association with reduced drug-related choice.Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependenceIn vivo imaging of cerebral dopamine D3 receptors in alcoholism.Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation.Getting a grip on problem gambling: what can neuroscience tell us?Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO.Cocaine dependent individuals with attenuated striatal activation during reinforcement learning are more susceptible to relapse.Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopyCocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28.New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivityTreatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.Measures of attentional bias and relational responding are associated with behavioral treatment outcome for cocaine dependencePharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Weak ventral striatal responses to monetary outcomes predict an unwillingness to resist cigarette smoking.Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation.The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an updateStriatal ups and downs: their roles in vulnerability to addictions in humansDecreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictorsPharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Neuroimaging and biomarkers in addiction treatment.Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction.Decreased dopamine activity predicts relapse in methamphetamine abusers.Dysbalance of cortical inhibition and excitation in abstinent cocaine-dependent patientsBrain pathways to recovery from alcohol dependenceClinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent SubjectsIn vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers
P2860
Q26801102-ADCE4F0D-15FE-41AB-9DC3-617C4CFB3A4EQ26829186-46382B79-ED40-4F0A-8906-C6BF4A882589Q27014737-189E9E76-FB42-42A3-8B3D-0A5183CB6A84Q27027961-EA118946-05F2-480D-8314-9AA3C9ADC87AQ28267550-563B27C5-82C4-4188-A23D-986428C135A7Q28602506-88CB38EA-36BA-421C-B141-AA504BAB9CE4Q30362023-602EDB0B-65DE-4254-BEF3-0C53C24DCD71Q30403978-3FECC647-DCB2-4758-B836-61C8A047C127Q30422045-9AF4B79F-C6F2-45F1-A0A3-2F1859FBC1C3Q30447620-937C2E19-0D67-4754-BADF-D04296C3DBFCQ30453617-B5A85CEE-D73D-44CE-954B-66C38E1CECF7Q33620597-784CBAFD-FAE3-4BD6-8B01-E1DCFDFD61B8Q33648162-5278E577-4DAF-45B2-BD94-F25A40F80FF4Q33658552-9A6202E3-DFE0-4D6D-AB4C-B07E50415A16Q33700413-3A0F2B11-4C55-4EEC-BD60-917AB301EC6CQ33809050-BA6A9DB0-9DB4-4F29-80AF-1E1A69DABB5FQ33894248-5D8B611A-FE04-4788-BA4E-CB48CFBD2216Q33930038-99DF338F-5F24-4200-B643-42A81365B7F8Q33936013-61F36D3B-FA77-41D2-B87E-425158099007Q33961196-A807C288-F225-4CCF-BFAB-3A73C958793FQ33998159-A2EAC710-C9D2-41B0-9224-C2BD7BB67AFCQ34244844-C3A5AFF9-F05E-4ED6-803F-403306C7277EQ34253787-CE7E9474-62DF-4E66-A3D6-B2D9C6F10111Q34422430-2BF30114-2F3E-4DAC-AAE5-5603345C9D5BQ34442240-6CF32A46-F18A-4DF3-ACD1-2C6501E89915Q34487773-539DF74E-BDCE-4BB6-AD02-A78C66F70FA9Q34554828-2AC4FF19-65D4-4C5C-8995-D4BF9CD19065Q34765909-09F3B843-9070-45A3-9112-D464244C4EB2Q35174502-72869A5D-2A88-4ADF-AAB6-93A00A57076AQ35576598-5BA18774-2F2A-4D6C-B164-C4A67EFFB4FCQ35594897-0BBD65FD-F9AE-4AA5-9770-95E0395EB446Q35661488-B22FA098-3340-4B01-9D7F-911BD265BBB3Q35680896-0CFF4958-B266-45FE-A851-BF0728D1C4F8Q35690913-84119107-D847-4723-91DB-8C485C1FF67AQ35746391-53704716-CF0D-495D-992F-5DB1E52DE3C4Q35766564-1ADD23DE-CB60-4C9B-9F82-D4A03D927E2EQ35857033-53174F4D-80E8-47E5-BA79-8203EF7D26C0Q35965848-E94F84B2-E627-4E7F-8F7D-31B2EDA40567Q35990520-FBD5BA13-8983-40BF-B07D-801A1044664CQ36118252-6EF4B60B-23FE-43A4-AC48-78713FB74EA5
P2860
Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Imaging dopamine transmission ...... stry and response to treatment
@ast
Imaging dopamine transmission ...... stry and response to treatment
@en
type
label
Imaging dopamine transmission ...... stry and response to treatment
@ast
Imaging dopamine transmission ...... stry and response to treatment
@en
prefLabel
Imaging dopamine transmission ...... stry and response to treatment
@ast
Imaging dopamine transmission ...... stry and response to treatment
@en
P2093
P2860
P1476
Imaging dopamine transmission ...... stry and response to treatment
@en
P2093
Alessandra Calvo Friedman
Allegra Broft
Diana Martinez
Dileep Kumar
Edward Nunes
Herbert D Kleber
Kenneth M Carpenter
Mark Slifstein
Ronald Van Heertum
P2860
P304
P356
10.1176/APPI.AJP.2010.10050748
P407
P577
2011-03-15T00:00:00Z